» Articles » PMID: 33080171

Functional Diversification of SRSF Protein Kinase to Control Ubiquitin-Dependent Neurodevelopmental Signaling

Abstract

Conserved protein kinases with core cellular functions have been frequently redeployed during metazoan evolution to regulate specialized developmental processes. The Ser/Arg (SR)-rich splicing factor (SRSF) protein kinase (SRPK), which is implicated in splicing regulation, is one such conserved eukaryotic kinase. Surprisingly, we show that SRPK has acquired the capacity to control a neurodevelopmental ubiquitin signaling pathway. In mammalian embryonic stem cells and cultured neurons, SRPK phosphorylates Ser-Arg motifs in RNF12/RLIM, a key developmental E3 ubiquitin ligase that is mutated in an intellectual disability syndrome. Processive phosphorylation by SRPK stimulates RNF12-dependent ubiquitylation of nuclear transcription factor substrates, thereby acting to restrain a neural gene expression program that is aberrantly expressed in intellectual disability. SRPK family genes are also mutated in intellectual disability disorders, and patient-derived SRPK point mutations impair RNF12 phosphorylation. Our data reveal unappreciated functional diversification of SRPK to regulate ubiquitin signaling that ensures correct regulation of neurodevelopmental gene expression.

Citing Articles

Dynamic mRNA Stability Buffer Transcriptional Activation During Neuronal Differentiation and Is Regulated by SAMD4A.

Zhou Y, Rashad S, Ando D, Kobayashi Y, Tominaga T, Niizuma K J Cell Physiol. 2024; 240(1):e31477.

PMID: 39513231 PMC: 11747957. DOI: 10.1002/jcp.31477.


PIM-1L Kinase Binds to and Inactivates SRPK1: A Biochemical and Molecular Dynamics Study.

Lesgidou N, Koukiali A, Nikolakaki E, Giannakouros T, Vlassi M Proteins. 2024; 93(3):629-653.

PMID: 39462863 PMC: 11809128. DOI: 10.1002/prot.26757.


Integrated multi-omic high-throughput strategies across-species identified potential key diagnostic, prognostic, and therapeutic targets for atherosclerosis under high glucose conditions.

Shen Z, Zhao M, Lu J, Chen H, Zhang Y, Chen S Mol Cell Biochem. 2024; 480(3):1785-1805.

PMID: 39223351 DOI: 10.1007/s11010-024-05097-8.


Extending the clinical spectrum of X-linked Tonne-Kalscheuer syndrome (TOKAS): new insights from the fetal perspective.

Cuinat S, Quelin C, Effray C, Dubourg C, Le Bouar G, Cabaret-Dufour A J Med Genet. 2024; 61(9):824-832.

PMID: 38849204 PMC: 11420740. DOI: 10.1136/jmg-2024-109854.


How does the Xist activator Rlim/Rnf12 regulate Xist expression?.

Wang F, Mehta P, Bach I Biochem Soc Trans. 2024; 52(3):1099-1107.

PMID: 38747697 PMC: 11346418. DOI: 10.1042/BST20230573.


References
1.
Humphreys R, Zheng W, Prince L, Qu X, Brown C, Loomes K . Cranial neural crest ablation of Jagged1 recapitulates the craniofacial phenotype of Alagille syndrome patients. Hum Mol Genet. 2011; 21(6):1374-83. PMC: 3465692. DOI: 10.1093/hmg/ddr575. View

2.
Parada C, Han D, Grimaldi A, Sarrion P, Park S, Pelikan R . Disruption of the ERK/MAPK pathway in neural crest cells as a potential cause of Pierre Robin sequence. Development. 2015; 142(21):3734-45. PMC: 4647211. DOI: 10.1242/dev.125328. View

3.
. Large-scale discovery of novel genetic causes of developmental disorders. Nature. 2014; 519(7542):223-8. PMC: 5955210. DOI: 10.1038/nature14135. View

4.
Pawellek A, McElroy S, Samatov T, Mitchell L, Woodland A, Ryder U . Identification of small molecule inhibitors of pre-mRNA splicing. J Biol Chem. 2014; 289(50):34683-98. PMC: 4263873. DOI: 10.1074/jbc.M114.590976. View

5.
Smith-Hicks C . GABAergic dysfunction in pediatric neuro-developmental disorders. Front Cell Neurosci. 2014; 7:269. PMC: 3867664. DOI: 10.3389/fncel.2013.00269. View